Google
Trusted Resources: News & Events
Latest announcements and gatherings
Research Team Recognized for Organ-on-a-Chip Design
SCD is a group of genetic disorders that cause red blood cells to become misshapen and break down. From an early age, patients with sickle cell disease have a high risk of vascular disease and even stroke. Current models to test drugs used to treat SCD are not reliable and cannot accurately predict how a person’s body will respond to the medication. It is also difficult to predict which patients with the disease have the highest risk of suffering a stroke versus those who have the lowest.
The team is designing an organ-on-a-chip, consisting of a device that will mimic an artery of a pediatric sickle cell disease patient, and the associated biological readouts will provide information on the progression of vaso-occlusion, including during drug treatment.
+myBinderRelated Content
-
Mechanisms of Pain in Sickle Cell DiseaseObjectives: The hallmark of sickle cell...
-
Associations of Prolonged QTc in Sickle Cell DiseaseSudden death is a leading cause of morta...
-
When Cracking Down On Opioids Means Tougher Access For Sickle Cell PatientsMany people with sickle cell disease wil...
-
Living With Sickle Cell Disease Is a Constant Battle With Pain, According to one Woman Who Has It“You don’t look sick.” That’s ...
-
Safety and early hints of benefit seen in phase 1b trial of PF-04447943Sickle cell disease (SCD) patients were ...
-
How sickled red blood cells stick to blood vesselsOne of the most common complications o...
-
SCD Patients Benefit From Early Rivipansel Treatment for VOCs, New Analyses ShowStarting treatment with rivipansel (GMI-...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.